The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Semaglutide Therapy for Alcohol Reduction - Tulsa (STAR-T)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05891587
Recruitment Status : Recruiting
First Posted : June 7, 2023
Last Update Posted : November 7, 2023
Sponsor:
Collaborator:
National Institute of Drug Abuse
Information provided by (Responsible Party):
Oklahoma State University Center for Health Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2025
Estimated Study Completion Date : December 2025